[Macrophage activation syndrome and Kawasaki disease: Four new cases]

B Dumont1, P Jeannoel2, L Trapes3

  • 1Unité d'immuno-hématologie et oncologie pédiatrique, hôpital Nord, CHU de Saint-Étienne, 42055 Saint-Étienne cedex 2, France.

Insights

Macrophage activation syndrome (MAS) is a rare complication of Kawasaki disease (KD). Early recognition of MAS in KD is crucial for prompt treatment and favorable outcomes, as it can mimic other severe conditions.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Hematology

Background:

  • Kawasaki disease (KD) is a pediatric vasculitis. Macrophage activation syndrome (MAS) is a severe, life-threatening hyperinflammation. MAS is a rare but serious complication of KD.

Observation:

  • This report details four pediatric cases of KD complicated by MAS.
  • Clinical presentations included hepatosplenomegaly, thrombocytopenia, elevated serum ferritin, and bone marrow hemophagocytosis.
  • Presenting symptoms varied, including infectious spondylitis, acute myocarditis, multiorgan failure, and atypical KD.

Findings:

  • MAS in KD can mimic toxic shock or infection-associated hemophagocytic lymphohistiocytosis, complicating diagnosis.
  • Prompt treatment with intravenous immunoglobulins or steroids led to favorable outcomes in all reported cases.
  • No coronary artery aneurysms were observed in these patients post-MAS episode.

Implications:

  • KD should be recognized as an inflammatory condition that can precipitate MAS.
  • Identifying MAS in KD is critical for timely intervention and management.
  • The association of MAS with KD does not appear to negatively impact prognosis based on this series.